530 related articles for article (PubMed ID: 15254062)
1. Bone imaging in metastatic breast cancer.
Hamaoka T; Madewell JE; Podoloff DA; Hortobagyi GN; Ueno NT
J Clin Oncol; 2004 Jul; 22(14):2942-53. PubMed ID: 15254062
[TBL] [Abstract][Full Text] [Related]
2. Fusion of metabolic function and morphology: sequential [18F]fluorodeoxyglucose positron-emission tomography/computed tomography studies yield new insights into the natural history of bone metastases in breast cancer.
Du Y; Cullum I; Illidge TM; Ell PJ
J Clin Oncol; 2007 Aug; 25(23):3440-7. PubMed ID: 17592153
[TBL] [Abstract][Full Text] [Related]
3. [Bone metastases: new trends in diagnostic imaging].
Herneth AM; Dominkus M; Kurtaran A; Lang S; Rand T; Kainberger F
Wien Med Wochenschr Suppl; 2002; (113):92-4. PubMed ID: 12621852
[TBL] [Abstract][Full Text] [Related]
4. Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis.
Bäuerle T; Bartling S; Berger M; Schmitt-Gräff A; Hilbig H; Kauczor HU; Delorme S; Kiessling F
Eur J Radiol; 2010 Feb; 73(2):280-7. PubMed ID: 19070445
[TBL] [Abstract][Full Text] [Related]
5. Skeletal metastases: an update of the literature with pictorial review.
Zampakis P; Romanos O; Kraniotis P; Solomou EK
J BUON; 2011; 16(1):24-37. PubMed ID: 21674846
[TBL] [Abstract][Full Text] [Related]
6. The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET/CT.
Even-Sapir E; Metser U; Mishani E; Lievshitz G; Lerman H; Leibovitch I
J Nucl Med; 2006 Feb; 47(2):287-97. PubMed ID: 16455635
[TBL] [Abstract][Full Text] [Related]
7. Imaging of malignant bone involvement by morphologic, scintigraphic, and hybrid modalities.
Even-Sapir E
J Nucl Med; 2005 Aug; 46(8):1356-67. PubMed ID: 16085595
[TBL] [Abstract][Full Text] [Related]
8. The role of single-photon emission computed tomography/computed tomography in benign and malignant bone disease.
Horger M; Bares R
Semin Nucl Med; 2006 Oct; 36(4):286-94. PubMed ID: 16950146
[TBL] [Abstract][Full Text] [Related]
9. [Expert consensus on the diagnosis and treatment of bone metastasis and skeletal related events in breast cancer patients].
Collaborating study group on breast cancer bone metastasis
Zhonghua Zhong Liu Za Zhi; 2009 Feb; 31(2):156-9. PubMed ID: 19538898
[No Abstract] [Full Text] [Related]
10. Suggestions for diagnosing avascular necrosis of the hip in the 1990s.
Grimm ES; Blend MJ; Anderson TM
J Am Osteopath Assoc; 1992 Jun; 92(6):766-70, 775-6. PubMed ID: 1612942
[TBL] [Abstract][Full Text] [Related]
11. Evolving role of imaging modalities in inflammatory breast cancer.
Le-Petross CH; Bidaut L; Yang WT
Semin Oncol; 2008 Feb; 35(1):51-63. PubMed ID: 18308146
[TBL] [Abstract][Full Text] [Related]
12. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
13. Detection of occult bone metastases from head and neck squamous cell carcinoma: impact of positron emission tomography computed tomography with fluorodeoxyglucose F 18.
Basu D; Siegel BA; McDonald DJ; Nussenbaum B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):801-5. PubMed ID: 17709620
[TBL] [Abstract][Full Text] [Related]
14. Clinically available evaluation of bone disease in breast cancer--validity and cost effectiveness.
Coleman RE
Can J Oncol; 1995 Dec; 5 Suppl 1():69-79. PubMed ID: 8853529
[TBL] [Abstract][Full Text] [Related]
15. Bone imaging in prostate cancer.
Dotan ZA
Nat Clin Pract Urol; 2008 Aug; 5(8):434-44. PubMed ID: 18682719
[TBL] [Abstract][Full Text] [Related]
16. The relative use of eight collagenous and noncollagenous markers for diagnosis of skeletal metastases in breast, prostate, or lung cancer patients.
Leeming DJ; Koizumi M; Byrjalsen I; Li B; Qvist P; Tankó LB
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):32-8. PubMed ID: 16434583
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis of skeletal metastases and assessment of response to treatment.
Galasko CS
Clin Orthop Relat Res; 1995 Mar; (312):64-75. PubMed ID: 7634619
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic imaging of osteosarcoma.
Seeger LL; Gold RH; Chandnani VP
Clin Orthop Relat Res; 1991 Sep; (270):254-63. PubMed ID: 1884547
[TBL] [Abstract][Full Text] [Related]
19. Metastatic bone disease: evaluation by functional imaging in correlation with morphologic modalities.
Elgazzar AH; Kazem N
Gulf J Oncolog; 2009 Jan; (5):9-21. PubMed ID: 20084781
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen for diagnosis of bone metastases in patients with primary lung cancer.
Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
Respirology; 2005 Jun; 10(3):300-4. PubMed ID: 15955141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
